The Expert Panel for Cosmetic Ingredient Safety wants to see data that demonstrate prostaglandin analogs used in cosmetic products do not elicit effects that would identify them as drugs, adding to a long list of information it needs to review as it assesses the ingredients’ safety.
As drug safety is outside the panel’s remit, Cosmetic Ingredient Review has asked its independent experts to focus just on...





